A61P 1 - Drugs for disorders of the alimentary tract or the digestive system

Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
10/2004
10/07/2004	WO2004084919A1 Food for improving clinical conditions capable of lowering the concentration of low-molecular weight nitrogen-containing compounds in blood
10/07/2004	WO2004084904A1 A method of treating liver disease
10/07/2004	WO2004084899A1 Medicinal composition containing pyrrolopyridazine compound
10/07/2004	WO2004084892A1 Use of ritonavir for the treatment of unconjugated hyperbilirubinemia
10/07/2004	WO2004084891A1 Methods for treating inflammatory conditions or inhibiting jnk
10/07/2004	WO2004084889A1 Use of protein kinase c inhibitor for suppressing sustained slow postsynaptic excitation (sspe) of enteric neurons
10/07/2004	WO2004084886A1 THE USE OF BLOCKERS FOR THE LONG-TERM INHIBITION OF Na+-K+-ATPase AND/OR Na+/H+ EXCHANGE ACTIVITIES FOR THE PREPARATION OF A MEDICAMENT FOR THE INTESTINAL THERAPY
10/07/2004	WO2004084867A1 The colon-targeted pharmaceutical compositions of gastrointestinal motility drugs and their use
10/07/2004	WO2004067027A9 Osteogenic composition
10/07/2004	WO2004046134A3 Crystalline form ii of esomeprazole magnesium trihydrate and process for its preparation
10/07/2004	WO2004012659A3 Nitrosated proton pump inhibitors, compositions and methods of use
10/07/2004	WO2004002418A3 Compositions and methods comprising protein activated receptor antagonists
10/07/2004	WO2003099195A3 Immunomodulatory compounds and methods of use thereof
10/07/2004	WO2003068757A9 Novel pyridin- and pyrimidin-derivatives
10/07/2004	WO2003068748A9 Novel pyridine- and quinoline-derivatives
10/07/2004	WO2003057725A3 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
10/07/2004	WO2003053973A8 Pyrazolyl-substituted triazoloquinoxalines
10/07/2004	WO2003049679A3 Mitotic kinesin inhibitors
10/07/2004	WO2002100250A8 Wit 3.0, a novel gene to control soft tissue wound healing
10/07/2004	US20040198982 such as (4S)-1-(3-bromophenyl)-N-cyanomethyl)-4-methyl-prolinamide; for treatment of osteoporosis
10/07/2004	US20040198980 Selective rxr ligands
10/07/2004	US20040198979 antagonists of urotensin II; (R) N-[4-Chloro-3-(1-methyl-3-pyrrolidinyloxy)-phenyl]-[3-(2-chlorophenoxy)]benzenesulfonamide for example; treating various disease including cardiovascular disorders, gastrointestinal disorders, and psychological disorders
10/07/2004	US20040198976 Method for synthesizing pyrazolobenzodiazepines
10/07/2004	US20040198820 Orally administered dosage forms of gaba analog prodrugs having reduced toxicity
10/07/2004	US20040198801 Antiinflammatory agents; sepsis
10/07/2004	US20040198794 Ondansetron forms and processes of making the same
10/07/2004	US20040198792 Imidazole derivatives modulating the sodium channels
10/07/2004	US20040198791 Fused imidazole derivative
10/07/2004	US20040198781 Carbonic anhydrase inhibitor
10/07/2004	US20040198766 Chemical compounds
10/07/2004	US20040198764 Prodrugs of imidazopyridine derivatives
10/07/2004	US20040198749 Methods of using sodium channel blockers
10/07/2004	US20040198748 Antihistamines; bronchodilators; antiinflammatory agents; inflammatory bowel disorders
10/07/2004	US20040198747 Sodium channel blockers
10/07/2004	US20040198746 Sodium channel blockers
10/07/2004	US20040198745 Sodium channel blockers
10/07/2004	US20040198744 Methods of using phenolic guanidine sodium channel blockers
10/07/2004	US20040198737 Azaindoles
10/07/2004	US20040198735 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents
10/07/2004	US20040198726 Tri-and tetraaza-acenaphthylen derivatives as crf receptor antagonists
10/07/2004	US20040198725 A bi-heterocyclic compound e.g 3-methoxyphenyl)-{6-Morpholin-4-yl-2-[2-(pyridin-2-yloxy)-ethoxy]-9H-purin-8-yl}-amine or other derivatives useful for treating an interleukin-12 overproduction-related disorder such as rheumatoid arthritis, sepsis, Crohn's disease, multiple sclerosis, psoriasis or diabetes
10/07/2004	US20040198720 3-(Arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
10/07/2004	US20040198717 4-(trifluoromethyl)-7,8,9,10-tetrahydrochromeno[7,6-b]azepin-2(6H)-one and derivatives;4-(trifluoromethyl)-1,6,7,8,9,10-hexahydro-2H-azepino[3,2-g]quinolin-2-one and derivatives; useful in the treating conditions caused by androgen deficiency such as bone disorders
10/07/2004	US20040198688 for treatment of atopic conditions (dermatitis, allergies); point mutations
10/07/2004	US20040198677 macrolide and steroidal or non-steroidal substructures connected by an alkyl linker; esterification or amidation to couple; antiarthritic, antiasthmatic agents, nasal, gastrointestinal, dermatological and opthalmic disorders; veterinary or human therapy
10/07/2004	US20040198654 Glucagon-like peptide-1analogs
10/07/2004	US20040198651 Secreted proteins
10/07/2004	US20040198164 Manikin and eye device apparatus, methods and articles of manufacture
10/07/2004	US20040197889 cell free hepatitis b virus transcription/translation in escherichia plasmid; enzyme inhibitors; mimetics; viricides; shelf life
10/07/2004	US20040197876 Recombinant fusion proteins and the trimers thereof
10/07/2004	US20040197871 for diagnosing and treating inflammatory bowel disease using purified polypeptide; genetic engineering
10/07/2004	US20040197847 High throughput screening assays using fatty acid synthetic enzymes
10/07/2004	US20040197429 Selective COX-2 inhibition from plant extracts
10/07/2004	US20040197426 Use of phyllanthus constituents for treating or preventing infections caused by hepatit
10/07/2004	US20040197406 Stool softener and enteric coated bisacodyl; tablets, capsule; laxative; administering the drug
10/07/2004	US20040197404 Extended release oral dosage form
10/07/2004	US20040197345 Prostate derived Ets factor
10/07/2004	US20040197307 Mixture of human interferons
10/07/2004	US20040194793 Coated nicotine-containing chewing gum, manufacture and use thereof
10/07/2004	DE19943488B4 Mittel zur Behandlung von Tauben Agents for treating pigeons
10/07/2004	CA2520443A1 Methods for treating inflammatory conditions or inhibiting jnk
10/07/2004	CA2519761A1 Food for improving clinical conditions capable of lowering the concentration of low-molecular-weight nitrogen-containing compounds in blood
10/07/2004	CA2519051A1 Water-soluble thalidomide derivatives
10/07/2004	CA2517831A1 Use of ritonavir for the treatment of unconjugated hyperbilirubinemia
10/06/2004	EP1464706A2 HEK5, HEK7, HEK8, HEK11, EPH-like receptor protein tyrosine kinases
10/06/2004	EP1464335A2 Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist
10/06/2004	EP1464331A1 Compressed oral pharmaceutical dosage form, with an enteric coating, which contains an acid-labile benzimidazole compound
10/06/2004	EP1463823A2 Methods of increasing endogenous erythropoietin (epo)
10/06/2004	EP1463817A2 Histamine receptor h3 polynucleotides
10/06/2004	EP1463801A2 Transdifferentiation of pancreatic acinar cells
10/06/2004	EP1463799A2 Methods for the induction of professional and cytokine-producing regulatory cells
10/06/2004	EP1463759A1 Ligand for g-protein coupled receptor gpr43 and uses thereof
10/06/2004	EP1463756A2 Secreted proteins
10/06/2004	EP1463747A2 Novel antibodies that bind to antigenic polypeptides,nucleic acids encodings the antigens, and methodes of use
10/06/2004	EP1463743A1 Anhydrate/hydrate of an erythromycin derivative and processes for preparing said anhydrate/hydrate
10/06/2004	EP1463735A1 Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamides
10/06/2004	EP1463727A2 Heterocyclic compounds that are inhibitors of the enzyme dpp-iv
10/06/2004	EP1463726A2 Aromatic thioether liver x-receptor modulators
10/06/2004	EP1463716A1 Pyrrolidine and piperidine derivates as nk1 antagonists
10/06/2004	EP1463714A2 Vanilloid receptor ligands and their use in treatments
10/06/2004	EP1463707A2 A group of novel anti-cancer compounds with specific structure
10/06/2004	EP1463688A2 Use of an antimicrobial glass ceramic for dental care and oral hygiene
10/06/2004	EP1463525A2 Compositions and methods for the diagnosis and treatment of tumor
10/06/2004	EP1463509A1 Type 4 phosphodiesterase inhibitors and uses thereof
10/06/2004	EP1463498A1 Composition inhibiting matrix-metallproteinases for the treatment of neoplastic diseases
10/06/2004	EP1307262B1 Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity
10/06/2004	EP1303632B1 Galactomannan oligosaccharides and methods for the production and use thereof
10/06/2004	EP1248787B1 NOVEL SUBTITUTED PYRAZOLO[4,3-e]DIAZEPINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USE AS MEDICINAL PRODUCTS AND PROCESSES FOR PREPARING THEM
10/06/2004	EP1210325B1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha
10/06/2004	EP1185521B1 Substituted 1-aza-2-imino-heterocycles and their use as activators of nicotinic acetylcholine receptors
10/06/2004	EP1165516B1 Heterocyclic urea and related compounds useful as anti-inflammatory agents
10/06/2004	EP1154993B1 Thioamide derivatives
10/06/2004	EP1144403B1 Substituted pyrazoles as p38 kinase inhibitors
10/06/2004	EP1133284B1 A process for the preparation of crystalline particles
10/06/2004	EP1108050B1 Methods and compositions for expressing heterologous genes in hepatocytes using hepadnaviral vectors
10/06/2004	EP1027336B1 Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors
10/06/2004	EP0692024B1 An alpha-galactosidase enzyme
10/06/2004	CN1535312A PUFA polyketide synthase systems and uses thereof
10/06/2004	CN1535151A Novel anti-infectives
10/06/2004	CN1535148A Imidazole derivatives for moudlating sodium channels

1 ... 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 ... 1258